• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国间皮瘤发病率的时间趋势及未来病例预测:基于 1973 年至 2005 年 SEER 数据的更新

Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.

机构信息

Price Associates, Inc., White Plains, New York 10601, USA.

出版信息

Crit Rev Toxicol. 2009;39(7):576-88. doi: 10.1080/10408440903044928.

DOI:10.1080/10408440903044928
PMID:19650718
Abstract

The time trend of mesothelioma incidence and projections of future cases provide useful information for analyzing proposed public health interventions where asbestos exposure may be an issue, evaluating regulatory proposals, and estimating the remaining potential costs of programs to compensate individuals with asbestos-related diseases. We used the April 2008 release of Surveillance, Epidemiology, and End Results (SEER) data, which covers 1973 through 2005, to analyze the time trends in age-adjusted mesothelioma incidence and to estimate an age and birth-cohort model to project the number of future mesothelioma cases. The increase in the number of SEER cancer registries from 13 to 17 in 2000 had little effect on the time pattern of age-adjusted mesothelioma incidence, and the pattern over time of pleural mesothelioma was indistinguishable from the pattern for total mesothelioma defined as sum of pleural and peritoneal cases. Our analysis suggests that the SEER registries viewed as a sample of the U.S. population over-represents high mesothelioma incidence, a fact that we accounted for in our projections. For 2008 we estimate approximately 2,400 cases, with asbestos the likely cause in 58%. We project that asbestos will no longer be a factor in mesothelioma cases after the year 2042. For 2008 through 2042, we estimate slightly more than 68,000 total cases, with asbestos the likely cause in 34%.

摘要

间皮瘤发病率的时间趋势和未来病例的预测为分析拟议的公共卫生干预措施(其中石棉暴露可能是一个问题)、评估监管建议以及估计与石棉相关疾病患者赔偿计划的剩余潜在成本提供了有用的信息。我们使用了 2008 年 4 月发布的监测、流行病学和最终结果(SEER)数据(涵盖了 1973 年至 2005 年),来分析年龄调整后间皮瘤发病率的时间趋势,并估计年龄和出生队列模型来预测未来间皮瘤病例的数量。2000 年,SEER 癌症登记处从 13 个增加到 17 个,这对年龄调整后间皮瘤发病率的时间模式几乎没有影响,并且随时间推移的胸膜间皮瘤模式与总间皮瘤(定义为胸膜和腹膜病例的总和)模式无法区分。我们的分析表明,SEER 登记处作为美国人口的样本存在高估高间皮瘤发病率的情况,我们在预测中考虑到了这一事实。对于 2008 年,我们估计大约有 2400 例病例,其中 58%可能是石棉引起的。我们预测,到 2042 年之后,石棉将不再是间皮瘤病例的一个因素。对于 2008 年至 2042 年,我们估计总病例数略多于 68000 例,其中 34%可能是石棉引起的。

相似文献

1
Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.美国间皮瘤发病率的时间趋势及未来病例预测:基于 1973 年至 2005 年 SEER 数据的更新
Crit Rev Toxicol. 2009;39(7):576-88. doi: 10.1080/10408440903044928.
2
Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005.监测、流行病学与最终结果(SEER)数据库中的胸膜和腹膜间皮瘤:年龄效应及时间趋势,1973 - 2005年
Cancer Causes Control. 2009 Aug;20(6):935-44. doi: 10.1007/s10552-009-9328-9. Epub 2009 Mar 18.
3
[Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia].[布雷西亚省居民中确诊的190例恶性间皮瘤的发病率(1980 - 1999年)及石棉暴露情况]
Med Lav. 2001 Jul-Aug;92(4):249-62.
4
US mesothelioma patterns 1973-2002: indicators of change and insights into background rates.1973 - 2002年美国间皮瘤发病模式:变化指标及对背景发病率的洞察
Eur J Cancer Prev. 2008 Nov;17(6):525-34. doi: 10.1097/CEJ.0b013e3282f0c0a2.
5
[Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].[下诺曼底地区的恶性间皮瘤,一项法国人群研究。描述性分析、预后因素及生存情况]
Rev Epidemiol Sante Publique. 2001 Dec;49(6):523-9.
6
Malignant mesothelioma in Italy, 1997.1997年意大利的恶性间皮瘤
Am J Ind Med. 2004 Jan;45(1):55-62. doi: 10.1002/ajim.10313.
7
Analysis of current trends in United States mesothelioma incidence.美国间皮瘤发病率的当前趋势分析。
Am J Epidemiol. 1997 Feb 1;145(3):211-8. doi: 10.1093/oxfordjournals.aje.a009093.
8
Demographic patterns for mesothelioma in the United States.美国间皮瘤的人口统计学模式。
J Natl Cancer Inst. 1987 Jun;78(6):1053-60.
9
[The incidence of malignant mesothelioma (1977-1996) and asbestos exposure in the population of an area neighboring Lake Iseo, northern Italy].[意大利北部伊塞奥湖附近地区人群中恶性间皮瘤的发病率(1977 - 1996年)及石棉暴露情况]
Med Lav. 1999 Nov-Dec;90(6):762-75.
10
Explaining Alberta's rising mesothelioma rates.解读艾伯塔省间皮瘤发病率上升的原因。
Chronic Dis Can. 2009;29(4):144-52.

引用本文的文献

1
A rare presentation of peritoneal mesothelioma: Esophageal encasement and Sister Mary Joseph nodule.腹膜间皮瘤的罕见表现:食管包绕及玛丽·约瑟夫修女结节。
Radiol Case Rep. 2025 Aug 7;20(11):5407-5410. doi: 10.1016/j.radcr.2025.07.033. eCollection 2025 Nov.
2
An evaluation of trends for mesothelioma mortality in American women: Addressing the content of a recent Morbidity and Mortality Weekly Report (MMWR).美国女性间皮瘤死亡率趋势评估:解读近期的《发病率与死亡率周报》(MMWR)内容
Toxicol Ind Health. 2025 Jan;41(1):40-60. doi: 10.1177/07482337241293201. Epub 2024 Oct 24.
3
Trends in Asbestos Exposure and Malignant Mesothelioma Incidence in Emilia-Romagna Italy: A Retrospective Study 1996-2023.
意大利艾米利亚-罗马涅地区石棉暴露与恶性间皮瘤发病率趋势:一项回顾性研究 1996-2023 年。
Med Lav. 2024 Aug 27;115(4):e2024028. doi: 10.23749/mdl.v115i4.16005.
4
The lncRNAs Gas5, MALAT1 and SNHG8 as diagnostic biomarkers for epithelial malignant pleural mesothelioma in Egyptian patients.lncRNAs Gas5、MALAT1 和 SNHG8 作为埃及患者上皮性恶性胸膜间皮瘤的诊断生物标志物。
Sci Rep. 2024 Feb 27;14(1):4823. doi: 10.1038/s41598-024-55083-9.
5
The genetic susceptibility in the development of malignant pleural mesothelioma: somatic and germline variants, clinicopathological features and implication in practical medical/surgical care: a narrative review.恶性胸膜间皮瘤发生中的遗传易感性:体细胞和种系变异、临床病理特征及其在实际医学/外科治疗中的意义:一项叙述性综述
J Thorac Dis. 2024 Jan 30;16(1):671-687. doi: 10.21037/jtd-23-611. Epub 2024 Jan 10.
6
Occupational exposure to asbestos in the steel industry (1972-2006).钢铁行业职业性接触石棉(1972-2006 年)。
J Expo Sci Environ Epidemiol. 2024 May;34(3):465-495. doi: 10.1038/s41370-023-00576-4. Epub 2023 Jul 26.
7
Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma.个体化预测恶性胸膜间皮瘤患者术后放疗的生存获益。
Cancer Med. 2023 Jun;12(11):12452-12461. doi: 10.1002/cam4.5955. Epub 2023 Apr 19.
8
Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma.临床和分子验证 BAP1、MTAP、P53 和 Merlin 免疫组化在胸膜间皮瘤诊断中的应用。
Mod Pathol. 2022 Oct;35(10):1383-1397. doi: 10.1038/s41379-022-01081-z. Epub 2022 Apr 22.
9
The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.影像学在恶性腹膜间皮瘤诊断与管理中的作用:一项系统评价
Abdom Radiol (NY). 2022 May;47(5):1725-1740. doi: 10.1007/s00261-022-03464-x. Epub 2022 Mar 7.
10
Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis.18F-FDG PET/CT的最大标准摄取值、代谢肿瘤体积和总病变糖酵解对恶性胸膜间皮瘤患者的预后价值:一项系统评价和荟萃分析
Cancer Cell Int. 2022 Feb 3;22(1):60. doi: 10.1186/s12935-022-02482-5.